Search Results

There are 4163 results for: content related to: Single therapeutic and supratherapeutic doses of anacetrapib, a cholesteryl ester transfer protein inhibitor, do not prolong the QTcF interval in healthy volunteers

  1. You have free access to this content
    Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)

    Intervention Review

    The Cochrane Library

    Lilia E Ziganshina, Albina F Titarenko and Geraint R Davies

    Published Online : 6 JUN 2013, DOI: 10.1002/14651858.CD004795.pub4

  2. You have free access to this content
    Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects

    British Journal of Clinical Pharmacology

    Volume 77, Issue 1, January 2014, Pages: 170–179, Jorg Taubel, Georg Ferber, Ulrike Lorch, Velislav Batchvarov, Irina Savelieva and A. John Camm

    Version of Record online : 20 DEC 2013, DOI: 10.1111/bcp.12168

  3. You have free access to this content
    Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin

    British Journal of Pharmacology

    Volume 147, Issue 8, April 2006, Pages: 905–916, Ari J Alexandrou, Rona S Duncan, Anneli Sullivan, Jules C Hancox, Derek J Leishman, Harry J Witchel and Joanne L Leaney

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706678

  4. You have free access to this content
    Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 549–564, Corina Loghin, Harry Haber, Charles M. Beasley Jr, Prajakti A. Kothare, Lynnette Kauffman, John April, Ling Jin, Albert J. Allen and Malcolm I. Mitchell

    Version of Record online : 10 JAN 2013, DOI: 10.1111/j.1365-2125.2012.04382.x

  5. Monocarboxylate transporter mediated uptake of moxifloxacin on human retinal pigmented epithelium cells

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 4, April 2014, Pages: 574–583, Megha Barot, Mitan R. Gokulgandhi, Vibhuti Agrahari, Dhananjay Pal and Ashim K. Mitra

    Version of Record online : 1 SEP 2013, DOI: 10.1111/jphp.12139

  6. You have free access to this content
    In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study

    Clinical Microbiology and Infection

    Volume 9, Issue 10, October 2003, Pages: 997–1005, C.-J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R. Leclercq, H. Drugeon, P. Cavallo, H. Chardon, J. Etienne, Y. Rio and P. Courvalin

    Version of Record online : 17 OCT 2003, DOI: 10.1046/j.1469-0691.2003.00696.x

  7. Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study

    British Journal of Clinical Pharmacology

    Volume 80, Issue 3, September 2015, Pages: 446–459, Joel Morganroth, Yaning Wang, Michael Thorn, Yuji Kumagai, Stuart Harris, Norman Stockbridge, Robert Kleiman and Rashmi Shah

    Version of Record online : 2 JUL 2015, DOI: 10.1111/bcp.12684

  8. Drug–drug interactions between moxifloxacin and rifampicin based on pharmacokinetics in vivo in rats

    Biomedical Chromatography

    Lifei Huang, Jiajun Liu, Xin Yu, Lei Shi, Jian Liu, Heping Xiao and Yi Huang

    Version of Record online : 28 APR 2016, DOI: 10.1002/bmc.3726

  9. You have full text access to this OnlineOpen article
    Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects

    The Journal of Clinical Pharmacology

    Volume 54, Issue 9, September 2014, Pages: 995–1005, Justin A. Green, Apurva K. Patel, Bela R. Patel, Azra Hussaini, Emma J. Harrell, Mirna J. McDonald, Nick Carter, Khadeeja Mohamed, Stephan Duparc and Ann K. Miller

    Version of Record online : 9 APR 2014, DOI: 10.1002/jcph.302

  10. Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 30, Issue 6, December 2007, Pages: 586–591, A. M. ABD EL-ATY, A. GOUDAH, S. S. SHAH, H.-C. SHIN, M. SHIMODA and J.-H. SHIM

    Version of Record online : 24 OCT 2007, DOI: 10.1111/j.1365-2885.2007.00908.x

  11. You have free access to this content
    Fluoroquinolones I

    Clinical Microbiology and Infection

    Volume 5, Issue s3, March 1999, Pages: 138–148,

    Version of Record online : 27 OCT 2008, DOI: 10.1111/j.1469-0691.1999.tb00799.x

  12. You have full text access to this OnlineOpen article
    Effects of subcutaneous pasireotide on cardiac repolarization in healthy volunteers: A single-center, phase I, randomized, four-way crossover study

    The Journal of Clinical Pharmacology

    Volume 54, Issue 1, January 2014, Pages: 75–86, Astrid Breitschaft, Ke Hu, Christelle Darstein, Monica Ligueros-Saylan, Pierre Jordaan, Dongweon Song, Michelle Hudson and Rashmi Shah

    Version of Record online : 16 NOV 2013, DOI: 10.1002/jcph.213

  13. You have free access to this content
    Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes

    British Journal of Pharmacology

    Volume 165, Issue 2, January 2012, Pages: 467–478, L Nalos, R Varkevisser, MKB Jonsson, MJC Houtman, JD Beekman, R van der Nagel, MB Thomsen, G Duker, P Sartipy, TP de Boer, M Peschar, MB Rook, TAB van Veen, MAG van der Heyden and MA Vos

    Version of Record online : 16 DEC 2011, DOI: 10.1111/j.1476-5381.2011.01558.x

  14. Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate

    Helicobacter

    Volume 14, Issue 5, October 2009, Pages: 429–437, Hyuk Yoon, Nayoung Kim, Byoung Hwan Lee, Tae Jun Hwang, Dong Ho Lee, Young Soo Park, Ryoung Hee Nam, Hyun Chae Jung and In Sung Song

    Version of Record online : 9 SEP 2009, DOI: 10.1111/j.1523-5378.2009.00709.x

  15. You have free access to this content
    Effect of moxifloxacin on survival, lipid peroxidation and inflammation in immunosuppressed rats with soft tissue infection caused by Stenotrophomonas maltophilia

    Microbiology and Immunology

    Volume 58, Issue 2, February 2014, Pages: 96/n–102, Orestis Ioannidis, Basilios Papaziogas, Panagiotis Tsiaousis, George Paraskevas, Evangelos J. Giamarellos-Bourboulis and Ioannis Koutelidakis

    Version of Record online : 17 FEB 2014, DOI: 10.1111/1348-0421.12124

  16. Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach

    British Journal of Pharmacology

    Volume 173, Issue 8, April 2016, Pages: 1373–1380, Gopi Krishna Panicker, Dilip R Karnad, Pramod Kadam, Fabio Badilini, Anil Damle and Snehal Kothari

    Version of Record online : 4 MAR 2016, DOI: 10.1111/bph.13436

  17. You have free access to this content
    Comparative Analysis of Length of Stay, Total Costs, and Treatment Success between Intravenous Moxifloxacin 400 mg and Levofloxacin 750 mg among Hospitalized Patients with Community-Acquired Pneumonia

    Value in Health

    Volume 12, Issue 8, November/December 2009, Pages: 1135–1143, Howard Friedman, Xue Song, Simone Crespi and Prakash Navaratnam

    Version of Record online : 20 AUG 2009, DOI: 10.1111/j.1524-4733.2009.00576.x

  18. Population Pharmacokinetic and Concentration—QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies

    The Journal of Clinical Pharmacology

    Volume 51, Issue 8, August 2011, Pages: 1152–1162, Dr Jeffry A. Florian, Dr Christoffer W. Tornøe, Dr Richard Brundage, Dr Ameeta Parekh and Dr Christine E. Garnett

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010381498

  19. You have free access to this content
    No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block

    British Journal of Pharmacology

    Volume 149, Issue 8, December 2006, Pages: 1039–1048, M B Thomsen, J D M Beekman, N J M Attevelt, A Takahara, A Sugiyama, K Chiba and M A Vos

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706900

  20. Fluoroquinolones in the management of community-acquired pneumonia

    International Journal of Clinical Practice

    Volume 64, Issue 3, February 2010, Pages: 378–388, T. E. Albertson, N. C. Dean, A. A. El Solh, M. H. Gotfried, C. Kaplan and M. S. Niederman

    Version of Record online : 11 JAN 2010, DOI: 10.1111/j.1742-1241.2009.02239.x